{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:07:59Z","timestamp":1778728079093,"version":"3.51.4"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006574","name":"Minist\u00e8re de l'Enseignement Sup\u00e9rieur, de la Recherche Scientifique et de la Formation des Cadres","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006574","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016992","name":"Universit\u00e9 Hassan II de Casablanca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016992","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006319","name":"National Center For Scientific and Technical Research","doi-asserted-by":"publisher","award":["79 UH2C2023"],"award-info":[{"award-number":["79 UH2C2023"]}],"id":[{"id":"10.13039\/501100006319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.bulcan.2025.12.019","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T12:48:39Z","timestamp":1772714919000},"page":"562-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Genetic effects of vascular endothelial growth factor A (VEGF-A) gene mutations and their association with poor clinical characteristics of prostate cancer"],"prefix":"10.1016","volume":"113","author":[{"given":"Khaoula","family":"Elghazali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youssef","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelilah","family":"Laraqui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Ennibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moulay Mustapha","family":"Ennaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2025.12.019_bib0170","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.bulcan.2025.12.019_bib0175","doi-asserted-by":"crossref","first-page":"e2433546","DOI":"10.1001\/jamanetworkopen.2024.33546","article-title":"West African genetic ancestry, neighborhood deprivation, and prostate cancer","volume":"7","author":"Pichardo","year":"2024","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.bulcan.2025.12.019_bib0180","series-title":"Mechanisms of Angiogenesis. Experientia Supplementum 94","article-title":"The role of VEGF in the regulation of physiological and pathological angiogenesis","author":"Ferrara","year":"2005"},{"issue":"21","key":"10.1016\/j.bulcan.2025.12.019_bib0185","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1200\/JCO.2002.10.088","article-title":"Vascular permeability factor\/vascular endothelial growth factor: a critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy","volume":"20","author":"Dvorak","year":"2002","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.bulcan.2025.12.019_bib0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","article-title":"Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis","volume":"312","author":"Shibuya","year":"2006","journal-title":"Exp Cell Res"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nm0195-27","article-title":"Angiogenesis in cancer, vascular, rheumatoid and other disease","volume":"1","author":"Folkman","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.bulcan.2025.12.019_bib0200","doi-asserted-by":"crossref","first-page":"879623","DOI":"10.1155\/2012\/879623","article-title":"Tumor angiogenesis as a target for dietary cancer prevention","volume":"2012","author":"Li","year":"2012","journal-title":"J Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0205","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/jcm9010084","article-title":"Tumor angiogenesis and anti-angiogenic strategies for cancer treatment","volume":"9","author":"Teleanu","year":"2019","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.bulcan.2025.12.019_bib0210","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/bjh.15000","article-title":"Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases","volume":"180","author":"Yang","year":"2018","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.12.019_bib0215","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0220","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1086\/679704","article-title":"Vascular endothelial growth factor receptor 3 signaling contributes to angioobliterative pulmonary hypertension","volume":"5","author":"Al-Husseini","year":"2015","journal-title":"Pulm Circ"},{"issue":"5","key":"10.1016\/j.bulcan.2025.12.019_bib0225","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3390\/ijms19051269","article-title":"VEGF (vascular endothelial growth factor) and fibrotic lung disease","volume":"19","author":"Barratt","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bulcan.2025.12.019_bib0230","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.03.010","article-title":"Vascular endothelial growth factor (VEGF) and VEGF receptor inhibitors in the treatment of renal cell carcinomas","volume":"120","author":"Roskoski","year":"2017","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.bulcan.2025.12.019_bib0235","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/sj.bjc.6603487","article-title":"The role of the VEGF-C\/VEGFR-3 axis in cancer progression","volume":"96","author":"Su","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bulcan.2025.12.019_bib0240","doi-asserted-by":"crossref","first-page":"418340","DOI":"10.1155\/2013\/418340","article-title":"The role of vascular endothelial growth factor in metastatic prostate cancer to the skeleton","volume":"2013","author":"Roberts","year":"2013","journal-title":"Prostate Cancer"},{"issue":"5","key":"10.1016\/j.bulcan.2025.12.019_bib0245","first-page":"1155","article-title":"Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer","volume":"18","author":"Fukuda","year":"2007","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0250","doi-asserted-by":"crossref","first-page":"139","DOI":"10.31557\/APJCP.2020.21.1.139","article-title":"Genetic effects of vascular endothelial growth factor A (VEGF-A) and its association with disease progression in breast cancer population of Saudi Arabia","volume":"21","author":"Albalawi","year":"2020","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.bulcan.2025.12.019_bib0255","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12032-013-0509-8","article-title":"Association of single nucleotide polymorphisms in vascular endothelial growth factor gene with bladder cancer risk","volume":"30","author":"Jaiswal","year":"2013","journal-title":"Med Oncol"},{"issue":"6","key":"10.1016\/j.bulcan.2025.12.019_bib0260","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.21873\/anticanres.13419","article-title":"Associations between gene polymorphisms of vascular endothelial growth factor and prostate cancer","volume":"39","author":"Drobkov\u00e1","year":"2019","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijc.10552","article-title":"VEGF isoforms and mutations in human colorectal cancer","volume":"101","author":"Uthoff","year":"2002","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2025.12.019_bib0270","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1200\/JCO.2007.13.5947","article-title":"VEGF polymorphisms and survival in early-stage non-small-cell lung cancer","volume":"26","author":"Heist","year":"2008","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.bulcan.2025.12.019_bib0275","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.3390\/diagnostics13081471","article-title":"The evaluation of vascular endothelial growth factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer","volume":"13","author":"El Azzouzi","year":"2023","journal-title":"Diagnostics"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0280","first-page":"1072","article-title":"Evaluation of VEGF and PEDF in prostate cancer: a preliminary study in serum and biopsies","volume":"15","author":"Rivera-P\u00e9rez","year":"2018","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.bulcan.2025.12.019_bib0285","first-page":"305","article-title":"Expression analysis of peptide growth factors VEGF, FGF2, TGFB1, EGF and IGF1 in prostate cancer and benign prostatic hyperplasia","volume":"29","author":"Soulitzis","year":"2006","journal-title":"Int J Oncol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0290","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3892\/mmr.2014.2198","article-title":"Peroxisome proliferator-activated receptor \u03b3 ligands inhibit VEGF-mediated vasculogenic mimicry of prostate cancer through the AKT signaling pathway","volume":"10","author":"Qin","year":"2014","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/j.bulcan.2025.12.019_bib0295","doi-asserted-by":"crossref","first-page":"4065","DOI":"10.3892\/ol.2017.6726","article-title":"Relationship between the expression of CD133, HIF-1\u03b1, VEGF and the proliferation and apoptosis in hypoxic human prostate cancer cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.bulcan.2025.12.019_bib0300","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.3892\/ijo.2013.2116","article-title":"A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1\u03b1 and VEGF expression, and migration in human prostate cancer cells","volume":"43","author":"Kim","year":"2013","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.12.019_bib0305","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3892\/or.2016.4997","article-title":"Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs","volume":"36","author":"Huang","year":"2016","journal-title":"Oncol Rep"},{"issue":"3","key":"10.1016\/j.bulcan.2025.12.019_bib0310","first-page":"737","article-title":"Obesity, adipokines, and prostate cancer (review)","volume":"28","author":"Baillargeon","year":"2006","journal-title":"Int J Oncol"},{"issue":"3","key":"10.1016\/j.bulcan.2025.12.019_bib0315","first-page":"469","article-title":"MMAC\/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer","volume":"21","author":"Koul","year":"2002","journal-title":"Int J Oncol"},{"issue":"2","key":"10.1016\/j.bulcan.2025.12.019_bib0320","doi-asserted-by":"crossref","first-page":"e30515","DOI":"10.1002\/jcb.30515","article-title":"Nonsynonymous mutations in VEGF receptor binding domain alter the efficacy of bevacizumab treatment","volume":"125","author":"Ahamed","year":"2024","journal-title":"J Cell Biochem"},{"issue":"7","key":"10.1016\/j.bulcan.2025.12.019_bib0325","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1158\/0008-5472.CAN-14-2305","article-title":"VEGF-A expression correlates with TP53 mutations in non-small cell lung cancer: implications for antiangiogenesis therapy","volume":"75","author":"Schwaederl\u00e9","year":"2015","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.bulcan.2025.12.019_bib0330","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1158\/1078-0432.CCR-22-1366","article-title":"Molecular mechanisms and future implications of VEGF\/VEGFR in cancer therapy","volume":"29","author":"Patel","year":"2023","journal-title":"Clin Cancer Res"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126001025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:14:45Z","timestamp":1778724885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126001025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0007455126001025"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.12.019","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic effects of vascular endothelial growth factor A (VEGF-A) gene mutations and their association with poor clinical characteristics of prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.12.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}